Michelina Cairo, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Topic:
    Ad board
    Date added:
    01/20/2024
    Date updated:
    01/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Gilead Sciences
    Topic:
    Speaker Bureau
    Date added:
    01/20/2024
    Date updated:
    01/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Astra Zeneca/Daiichi Sankyo
    Topic:
    Speaker Bureau
    Date added:
    01/20/2024
    Date updated:
    01/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Topic:
    Advisory board
    Date added:
    01/25/2025
    Date updated:
    01/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Biotheranostics
    Topic:
    Advisory Board
    Date added:
    01/25/2025
    Date updated:
    01/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Seagen
    Topic:
    Advisory bord
    Date added:
    01/25/2025
    Date updated:
    01/25/2025
Return to 2025 Updates in Hematology and Oncology, Houston